Technical Analysis for SAVA - Cassava Sciences, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
New 52 Week Closing Low | Bearish | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Down 3 Days in a Row | Weakness | 0.00% | |
Down 4 Days in a Row | Weakness | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
Doji - Bullish? | Reversal | -1.30% | |
Wide Bands | Range Expansion | -1.30% | |
Down 3 Days in a Row | Weakness | -1.30% | |
Oversold Stochastic | Weakness | -1.30% | |
Stochastic Buy Signal | Bullish | -1.83% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
Alert | Time |
---|---|
Fell Below Previous Day's Low | about 12 hours ago |
Down 1% | about 12 hours ago |
60 Minute Opening Range Breakdown | about 12 hours ago |
Up 1% | about 14 hours ago |
60 Minute Opening Range Breakout | 1 day ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/06/2023
Cassava Sciences, Inc. develops drugs for nervous system disorders in the United States. It engages in developing FENROCK, a proprietary abuse-deterrent transdermal pain patch for pain relief; PTI-125, a small molecule drug candidate to treat Alzheimer's disease; and PTI-125DX, a blood-based diagnostic/biomarker to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sciences, Inc. in March 2019. Cassava Sciences, Inc. was founded in 1998 and is based in Austin, Texas.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biology Pain Neuroscience Alzheimer's Disease Mental Health Biomarkers Nervous System Disorders Psychiatric Diagnosis Psychiatry Transdermal Abnormal Psychology
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biology Pain Neuroscience Alzheimer's Disease Mental Health Biomarkers Nervous System Disorders Psychiatric Diagnosis Psychiatry Transdermal Abnormal Psychology
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 46.29 |
52 Week Low | 16.55 |
Average Volume | 838,119 |
200-Day Moving Average | 24.59 |
50-Day Moving Average | 19.21 |
20-Day Moving Average | 18.96 |
10-Day Moving Average | 17.56 |
Average True Range | 0.93 |
RSI (14) | 31.51 |
ADX | 18.2 |
+DI | 18.11 |
-DI | 29.89 |
Chandelier Exit (Long, 3 ATRs) | 19.77 |
Chandelier Exit (Short, 3 ATRs) | 19.35 |
Upper Bollinger Bands | 22.08 |
Lower Bollinger Band | 15.85 |
Percent B (%b) | 0.13 |
BandWidth | 32.89 |
MACD Line | -0.79 |
MACD Signal Line | -0.52 |
MACD Histogram | -0.2625 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 17.46 | ||||
Resistance 3 (R3) | 17.52 | 17.31 | 17.32 | ||
Resistance 2 (R2) | 17.31 | 17.10 | 17.28 | 17.27 | |
Resistance 1 (R1) | 16.98 | 16.98 | 16.87 | 16.91 | 17.23 |
Pivot Point | 16.77 | 16.77 | 16.72 | 16.74 | 16.77 |
Support 1 (S1) | 16.43 | 16.56 | 16.33 | 16.37 | 16.05 |
Support 2 (S2) | 16.22 | 16.43 | 16.19 | 16.01 | |
Support 3 (S3) | 15.89 | 16.22 | 15.96 | ||
Support 4 (S4) | 15.82 |